Anatomy
The patellar tendon, the extension of the common tendon of insertion of the quadriceps femoris muscle, extends from the inferior pole of the patella to the tibial tuberosity. It is about 3 cm wide in the coronal plane and 4 to 5 mm deep in the sagittal plane. Macroscopically it appears glistening, stringy, and white. BLOOD 
SUPPLY
The blood supply has been postulated to contribute to patellar tendinopathy. 8 9 The patellar tendon receives its vascularisation through the anastomotic ring which lies in the thin layers of loose connective tissue covering the dense fibrous expansion of the rectus femoris. The main contributors are the medial inferior genicular, lateral superior genicular, lateral inferior genicular, and the anterior tibial recurrent artery. 10 11 The blood supply to the proximal portion of the patellar tendon enters precisely around the region that is most commonly aVected by patellar tendinopathythe proximal posterior aspect of the tendon.
A commonly held belief is that the patellar tendon has a "relatively avascular osseotendinous junction" (Scapinelli 11 quoted from McLoughlin et al 9 ). Scapinelli 11 reported that, although the distal attachment of the patellar tendon to the tibial tuberosity includes an "avascular zone between ligament and bone", the proximal attachment abuts the inferior half of the patella and the infrapatellar fat pad, both of which are richly vascularised. Thus the proximal patellar tendon is well vascularised. Blood flow at rest, however, does not necessarily correlate with blood flow during activity. Recent technical advances could permit further study of patellar tendon vasculature at rest and during quadriceps stretch and contraction. 12 
Mechanical loading in sport
Tendon displays a characteristic stress-strain curve 1 13 ( fig 1) . The classic crimped configuration of collagen fibres and fibrils at rest disappears when tendon is stretched by about 2%. 4 14 With further stretch to about 5% elongationthat is, load in sport-tendon fibres become more parallel and the tendon has a relatively 1 Collagen fibres slide past one another as cross links fail. 15 With even further strain, the tensile failure of fibres themselves, combined with shear failure, causes macroscopic damage in an unpredictable fashion. 15 A force of 0.5 kN is experienced in level walking, and forces within the patellar tendon may reach 8 kN during landing from a jump, up to 9 kN during fast running and 14.5 kN during competitive weight-lifting (about 17 times bodyweight). [16] [17] [18] Basketball players jump on average 70 times per game, and the vertical component of each ground reaction force in a jump is around six to eight body weights. 19 Thus sports activities can impose stresses high enough to cause fibre failure.
Patellar tendon pathology

NOMENCLATURE FOR TENDON PATHOLOGY
There is a lack of consistent nomenclature for histopathological findings, and a standardised nomenclature has been proposed 1 20 21 (table 2) .
PATHOLOGY OF JUMPER'S KNEE
As recently as 1994, the pathology underlying patellar tendinopathy was not clearly defined, 22 probably reflecting confusion arising from differences in nomenclature rather than a paucity of data. Macroscopically, the patellar tendon of patients with jumper's knee contain soft, 23 yellow-brown, and disorganised tissue [23] [24] [25] evident even to the naked eye. [26] [27] [28] [29] [30] [31] This macroscopic appearance is commonly labelled "mucoid" degeneration. 8 26 29-31 Occasionally, authors have reported "hyaline" degeneration, 25 27 which is characterised by hardness rather than the softness inherent in mucoid degeneration. 1 Under light microscopy, the tendon of patients with jumper's knee is characterised by abnormal collagen, tenocytes, and vasculature. It does not consist of tight parallel collagen bundles but appears amorphous and disorganised with collagen replaced by degenerative and necrotic tissue. Clefts in collagen suggest microtearing. 30 The characteristic reflective polarised light appearance of normal collagen is lost. 27 32 Alcianophilic ground substance, 32 consisting of glycosaminoglycans and proteoglycans, 33 is markedly increased. Tenocytes lose their fine spindle shape, and nuclei appear more rounded. 21 26 30 There is abnormal small vessel ingrowth. 8 26 30 31 Very similar histopathological changes occur in patients with Achilles tendinopathy. 34 The presence of inflammatory cells in the excision biopsy samples from patients with patellar tendinopathy is sometimes debated. Two recent papers, coauthored by specialist pathologist authors who analysed all specimens in each study, 27 32 reported the total absence of inflammatory cells from tissue from patients with jumper's knee, even at the periphery of abnormal tissue and in patients who had only had symptoms for four months. 32 Fibroblasts, however, were more plentiful than in the normal tendon, 8 26 29-31 35-37 and these may have appeared to be inflammatory cells to earlier authors. Papers reporting the presence of inflammatory cells have not mentioned staining methods or the expertise of the pathologist(s) reviewing specimens, 25 28 38-40 and only one 38 included a pathologist author. 25 28 39 40 This suggests that, in most cases, the tendons of patients suVering patellar tendinopathy appear to have a tendinosis, degenerative condition that would be expected to heal more slowly than an acute inflammatory condition. Thus sudden repeated tensile overloading may cause microtearing and fraying of tendon fibres followed by focal degeneration particularly at the tendon insertion to the patella. 39 41 Acute tendon ruptures are outside the scope of this review, but the pathology preceding such events is of interest. In 53 cases of spontaneous patellar tendon rupture, intratendinous pathology included hypoxic degenerative change, mucoid degeneration, tendolipomatosis, and calcifying tendinopathy or a combination of these subcategories of tendinosis. 42 Thus tendinosis preceded acute tendon rupture but remained symptomless in these cases. 43 These findings lead us to recommend that consistent nomenclature for tendon pathology (table 2) be widely adopted so that clear histological criteria exist for the conditions of paratenonitis, tendinosis, and the condition where these coexist (paratenonitis with tendinosis). It appears that intratendinous inflammation, "tendinitis", occurs mainly after tendon ruptures.
REPAIR OF MECHANICALLY DAMAGED TENDON
Because of its slow metabolic rate, tendon tissue was once thought to be inert. 45 46 Oxygen consumption of mature collagen is about 8-10 times lower than that of liver and skeletal muscle. 47 48 Tendon maintenance relies on the tenocyte producing collagen, a protein with a turnover time of 50 to 100 days. 49 50 When loading causes microdamage, tenocytes must increase collagen and matrix production. However, even when tenocyte metabolism is increased, tendon scar maturation remains a slow process. Animal experiments suggest that this may take four months in the calcaneal tendon of the rabbit and at least 14 months in the superficial digital flexor tendon of the horse. 51 If a tendon is given inadequate time to repair, tenocytes may die as the result of excessive strain. Collagen and matrix synthesis is then further reduced, making the remaining tissue even more vulnerable to further damage (fig 2) .
Clinical aspects
NOMENCLATURE
Athletes whose sports involve repetitive sudden ballistic movements of the knee may develop anterior knee pain associated with tenderness at the inferior pole of the patella, a clinical syndrome commonly called "jumper's knee". 35 In this condition ultrasound examination and magnetic resonance imaging (MR) reveal abnormal signals at the junction of the patella and the patellar tendon. Other names for this condition include "patellar tendinopathy", "patellar tendinosis", "patellar tendinitis", "patellar tendonitis", "patella tendon disorder", "insertion tendinitis of the patellar tendon", "partial rupture of the patellar tendon", and "patellar apicitis". "Peritendinitis of the patellar tendon" and acute ruptures are normally not encompassed by these terms.
However, as inflammatory peritendinous lesions can also contribute to patients' symptoms, we believe the term tendinopathy is the most appropriate clinical description for tendon conditions-that is, patellar tendinopathy, Achilles tendinopathy. 44 In our practice, the term patellar tendinopathy encompasses the lesion associated with pain and tenderness at the lower point of the patella and lesions of the main body of the tendon. 28 40 The latter are less common than the former and seem to involve the whole of the tendon instead of mainly its posterior aspect. 52 The term tendinopathy can be used to describe both acute and overuse conditions. This system of nomenclature avoids amibiguity as the terms tendinosis, paratendinitis, and tendinitis are reserved as pathological labels.
EPIDEMIOLOGY
Jumper's knee is most commonly seen in athletes from the sports of basketball, volleyball, football, soccer, high jump, long jump, tennis, and running, 35 53 54 as well as telemark and mogul skiing. As elite athletes appear to be aVected more than recreational athletes, 22 53 the frequency and intensity of training and competition may influence the development of symptoms. 55 Other skill factors, however, such as quick acceleration, deceleration, stopping, and cutting actions, [56] [57] [58] and greater jumping ability may also predispose to tendinopathy. 58 Anecdotal evidence and the gender ratio of patients in published clinical studies 59 suggest that patellar tendinopathy is more prevalent in Leadbetter. 20 Further reduction in collagen and matrix production Predisposition to further injury
Figure 2 A theoretical model illustrating how tendon injury may precipitate a vicious cycle ("tendinosis cycle") of further injury. Modified from
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Tenocyte death men than women, but no controlled studies have considered this question. Blazina et al 35 were the first authors to recognise that jumper's knee is not always a benign self limiting disorder. Symptoms can persist despite treatment, and there is a high rate of recurrence. 59 This condition has forced some elite athletes to retire prematurely.
HISTORY AND PHYSICAL EXAMINATION
The clinical diagnosis of patellar tendinopathy is based on patients' subjective reports of pain related to activity levels. 35 The onset of symptoms is often insidious, but usually relates to an increase in frequency or intensity of activity involving rapid repetitive ballistic movements of the knee joint. 53 Initially, athletic patients will complain of a dull ache in the anterior knee after strenuous activity. Athletes who continue to play with these symptoms eventually experience pain that interferes with performance. 35 Patients also commonly complain of pain when seated for long periods and when ascending and descending stairs.
The key physical finding in patellar tendinopathy is tenderness at the inferior pole of the patella or in the main body of the tendon when the knee is fully extended and the quadriceps relaxed. When the knee is flexed to 90 degrees, thus putting the tendon under tension, tenderness significantly decreases and often disappears altogether (J B King and N MaVulli, unpublished observations). There are generally few classical signs of soft tissue inflammation. 35 53 The main diVerential diagnosis is with the patellofemoral syndrome, 60 61 and the two conditions can coexist.
CLINICAL GRADING
There are several systems of grading jumper's knee according to the severity and timing of knee pain. 22 30 35 57 62 The reliability of these scales has never been tested, and they are often incapable of discriminating between patients with widely diVering symptoms. They cannot be used to grade recovery. Recently, we developed a 100 point scoring scale to assess severity of jumper's knee according to symptoms and function 63 ( fig 3) .
Imaging
Ultrasonography and MR are the imaging modalities of choice in patients with tendon disorders. 64 65 Although computed tomography can image the patellar tendon and has been shown to be of some prognostic value, 28 40 it does not oVer any significant advantage over methods not using ionising radiation.
ULTRASONOGRAPHIC APPEARANCE OF THE PATELLAR TENDON IN JUMPER'S KNEE
Patellar tendons in patients with jumper's knee have decreased echogenicity, containing either a focal sonolucent region ("cyst") or diVuse hypoechogenicity. 32 36 37 65-68 Irregularity of the tendinous envelope, intratendinous calcification, and erosion of the patellar tip also occur. 1 36 The characteristic sonographic hypoechogenic regions may represent fluid accumu- If you have pain that stops you from completing sporting activities, please complete Q8C only lation near hydrophilic proteoglycans of exposed intercellular matrix of the damaged tendon. 69 Ultrasonography has been used to (a) detect preclinical lesions in athletes, 22 (b) detect patellar tendon pathology, 29 (c) assess its severity, (d) monitor progress of the patellar tendon in patients being treated for patellar tendinopathy, 53 (e) provide objective indications for surgery, 36 37 (f) assess tendon healing after surgery, 70 and (g) image the remaining portions of the patellar tendon after its central third has been harvested for use as a graft for anterior cruciate ligament reconstruction. [71] [72] [73] [74] Can ultrasonography perform all of these roles?
CLINICAL UTILITY OF PATELLAR TENDON
57 Similarly, 15% of basketball players with no past history of knee pain had abnormal tendon morphology on ultrasonography. 75 Comparable findings have been reported in asymptomatic recreational athletes. 76 Furthermore, a longitudinal study found that hypoechoic ultrasound regions in asymptomatic sportswomen did not predict subsequent development of symptoms. 77 These data undermine the suggestion that ultrasonographic appearance can guide prognosis and management 29 and they emphasise that a sonographic hypoechoic region is not, of itself, an indication for surgery. 37 77 In the postoperative tendon, except in selected cases, 54 78 imaging does not appear to diVerentiate those patients who make a good recovery from those who continue to have tendon symptoms. 80 Information from studies of the patellar tendon donor site in anterior cruciate reconstruction surgery suggests that it takes the patella up to two years to regain a normal appearance on ultrasound examination. [71] [72] [73] [74] Therefore clinical judgment should take precedence over imaging appearance in postsurgical management.
MR OF THE PATELLAR TENDON
The abnormal patellar tendon contains an oval or round area of high signal intensity on T1-and T2-and the proton-density-weighted images at the tendon attachment or a focal zone of high signal intensity in the deep layers of the tendon insertion. 27 32 81 Tendons with patellar tendinopathy have increased anteroposterior diameter in the aVected region. 27 52 81 The T2-weighted sequences (particularly the T2*-weighted GRE sequences) have greater sensitivity than the T1-weighted protocols. 9 27 32 74 However, the T1-weighted signal can image most cases of patellar tendinopathy. In the Achilles tendon, MR detected abnormal tissue with greater sensitivity than ultrasonography. 82 In the patellar tendon, the area of high signal on T2*-weighted GRE sequence was significantly larger than the area of abnormal signal on ultrasound examination, 32 but the biological significance of this finding was not investigated.
CLINICAL UTILITY OF PATELLAR TENDON MR
MR scans could be used to identify the exact location and extent of tendon involvement, and help to exclude other clinical conditions such as bursitis and chondromalacia. 81 Surgeons could use MR to assess the severity of patellar tendon disease and determine how much tendon to excise. 27 81 Disadvantages of MR include cost and also slow and often incomplete resolution of signal changes after surgical intervention. 70 Whether MR abnormalities occur in asymptomatic patellar tendons has not been examined, but other tendons contain high-signal abnormality on MR in nearly a quarter of young volunteers. 83 Abnormal signal without change in size must be interpreted with caution, as the normal patellar tendon has a range of appearances because of technical factors and intrinsic fibre diVerences. 84 In particular, the "magic angle" phenomenon can result in false positive high-signal intensity on GRE T2*-weighted images of normal tendon. 32 85 86 Management of patellar tendinopathy Given the degree of morbidity associated with chronic tendon problems, and the extent of knowledge in certain areas of medical treatment, there is a surprising lack of scientific rationale for tendon treatment. 1 Conservative and operative treatments of tendinopathies vary considerably among surgeons and across countries. Unfortunately, "there is little scientific evidence for the majority of treatments proposed and used for chronic tendon problems". 70 Thus the treatment outlines suggested below are, at best, "empirical".
CONSERVATIVE MANAGEMENT
Conservative management regimens for jumper's knee are varied, and are usually based on the patient's subjective report of pain. Treatments include correction of predisposing factors, relative or absolute rest from aggravating high load activities, stretching and strengthening, physical therapy modalities, ice, massage, non-steroidal anti-inflammatory medication, corticosteroids by injection, or electrophoresis. 61 70 87 Rest The question of whether players with patellar tendinopathy should rest completely is difficult, but we believe that athletes who present with patellar tendinopathy for the first time have their best opportunity to make a full recovery by resting from competition and undergoing a complete conservative management programme (see below) before returning pain-free to their sport. This approach respects our knowledge of tendon pathology, as there is likely to be an area of substantial intratendinous degeneration even if symptoms are recent (fig 4) . This approach is advocated even in elite regular competitions-for example, an NBA season, premier league soccer, world league volleyball-but a compromise may be necessary immediately before one-oV tournaments such as World Championships or Olympic Games. This conservative approach is often unacceptable to players (who have little pain) and to coaches (who are paid to have short term goals). A poor alternative may be a period of rest and rehabilitation taken at the end of a season. 77 Decreasing the load on the tendon: technique, orthotics, braces, and straps One approach to healing tendon tissue is to decrease its loading. This can be achieved by an athlete decreasing the number of jumps-for example, adjusting his/her style of playing. Another way to decrease tendon loading in basketball and volleyball is for players to ensure that they land from jumps on two feet instead of one. In the heat of competition, however, this is not always feasible. Orthotic devices worn in shoes and boots may decrease the load on the patellar, as well as the Achilles, tendon in individuals with excessive pronation.
Knee braces and straps such as the Chopat strap are commonly used to alter the load on the tendon. The Chopat strap 61 (a tape attached just proximal to the patellar attachment to the tibia) supports the tibial attachment of the patellar tendon, but it probably does little to unload the insertion of the patellar tendon to the patella.
A new approach to patellar tendon bracing uses a semi-rigid patellar stay and buttress pad. Contained in a knee sleeve, this device aims to unload the quadriceps tendon and thus decrease the force transmitted through to the patellar tendon. As with other innovative therapies in patellar tendinopathy, rigorous research is required.
Cryotherapy and physical modalities
To control initial tissue response to tendon injury, most clinicians advise rest, cryotherapy, and anti-inflammatory medication (see below). Cryotherapy is thought to act by decreasing blood flow and metabolic rate, thereby limiting tissue damage. Electrical modalities that have been used in patellar tendinopathy include ultrasound, heat, interferential therapy, magnetic fields, pulsed magnetic and electromagnetic fields, transcutaneous electrical nerve stimulation (TENS), and laser. 1 61 88 Ultrasound is commonly used in tendinopathy but its eYcacy may be specific to wavelength and intensity. The true eVects of all of these modalities remain unknown and require further investigation. Our management of tendinopathies generally includes cryotherapy, ultrasound, laser, magnetic fields as well as pulsed magnetic and electromagnetic fields. 89 
Remedial massage
Remedial massage aims to treat tendon tissue by having an eVect on muscle stretch as well as by a direct eVect on tendon cells. Muscle belly massage is thought to increase muscle compliance and decrease load on the tendon. Deep friction tendon massage may activate mesenchymal stem cells to stimulate a healing response. A controlled study failed to find any positive eVects of massage treatment in patients with patellar tendinopathy. 90 However, "fibrolysis", a form of deep frictional massage originally developed in Finland, has been successful in Achilles tendinopathy. 91 Our clinical experience suggests that such a method warrants testing in the patellar tendon.
Rehabilitation
The stretching and strengthening programme of the whole muscle tendon unit of a chronically painful tendon is seen as a key treatment of patellar tendinopathy. Subclinical episode of failed adaptation rehabilitation methods have been described, but none has been scientifically tested as yet. Curwin and Stanish 92 suggest a three stage conservative programme for patellar tendinopathy which corresponds to three stages of worsening severity of the condition. 35 Stage 1 consists of adequate warm up, ice after activity, local anti-inflammatory treatments, including non-steroidal anti-inflammatory drugs (NSAIDs), physiotherapy, including isometric quadriceps exercises, and an elastic knee support. In stage 2 a period of rest is added, together with some form of heat before activity. In stage 3 a prolonged period of rest is added. 92 93 The key eccentric element described is the drop squat from standing to about 100-120°of knee flexion. Patients are advised to perform three sets of 10 repetitions per session (one session daily). 92 93 The proposers of this treatment programme emphasise the principles of training specificity, maximal loading, and progression. 94 95 In basketball and volleyball players, specificity is achieved by prescribing activities that mimic jumping. Maximal loading occurs when patients feel their tendon pain in the third set of 10 repetitions. Progression is achieved by increasing the speed of movement or by increasing the external resistance, again using pain as a guide. Ice is used to cool the tendon after the eccentric training. A modified version of this protocol as used by one of us (J E T) is reproduced (table 3) .
Some authors 94 95 contend that athletes often do not need to refrain from sport during this rehabilitation programme and that athletes become asymptomatic after six to eight weeks of exercise 92 Under close clinical supervision to adjust the programme as needed, 94 95 this regimen brought complete relief to 30% of patients and a marked decrease in symptoms to a further 64%. 92 The remaining 6% had worsening symptoms. In a randomised pilot study, Cannell 96 found that eccentric squat exercises were superior to leg curl/extension exercises in treatment of patellar tendinopathy. Given the natural history of patellar tendinopathy, these results are encouraging.
One of us (N M) advocates modified rest, with curtailment of the sport, or at least the component that causes the symptoms, to a level where pain is not experienced, and introduction of an alternative sport that does not load the tendon in the same way as the oVending sport. Patients undergo a six week period of supervised physiotherapy including basic stretching and eccentric training as outlined above. By the end of six weeks, one third of the patients seen early enough in their disease process generally do not need further management. It should be stressed, however, that, given the referral system in the British Isles, most patients reach a specialist sports surgeon after six to nine months of symptoms. By this time, they will have already undergone several periods of rest, physiotherapy, and often, two or more peritendinous injections. In such cases, although the above period of physiotherapy is recommended, their chances of needing surgery are relatively high, probably in the region of 50%.
NSAIDs
Although the benefit of NSAIDs in tendinopathies is not obvious, 1 97 they are probably the most commonly used symptomatic therapy. 98 In the only double blind placebo controlled study of the use of NSAIDs in tendinopathy, piroxicam did not benefit patients with Achilles tendinopathy. 99 Topical ketoprofen reached the target tissue in patients with patellar tendinopathy, but the clinical eYcacy was not assessed. 98 Although the use of "anti-inflammatory" medication seems paradoxical for a condition that is essentially degenerative, the NSAID family of drugs act in ways beyond their well known anti-inflammatory mode. 100 101 In human cartilage in vitro, some NSAIDs stimulate, and others inhibit, glycosaminoglycan synthesis. 102 If this also proves to be the case in vivo, it will provide a mechanism in tendons whereby NSAIDs could influence extracellular matrix. Thus it would appear premature to rule out any potential benefit of this class of medication merely because tendinopathy is not an inflammatory condition. 
Corticosteroids
Injection and infiltration-for example, iontophoresis-of corticosteroids is known to have a dramatic eVect on symptoms arising from inflamed synovial structures. 103 However, the role of corticosteroids in management of tendinopathy remains controversial. 104 105 The guidelines of Jozsa and Kannus 1 for appropriate use of corticosteroid injections should be adhered to in the absence of scientific evidence as to when these injections may be most appropriate (table 4) . It is noteworthy that after injection a tendon is at increased risk of rupture until appropriate strengthening has been undertaken. 1 
Other medical treatments
Recently, aprotinin has been trialled in the management of patellar tendinopathy. 106 Aprotinin, an 85 amino acid 65 kDa basic polypeptide extracted from bovine lungs, is a polyvalent inhibitor of the proteases collagenase, elastase, metalloprotease, kallikrein, plasmin, and cathepsin C. 107 At least in the short term, aprotinin (two to four injections of 62 500 IU with local anaesthetic in the paratendinous space) seems to oVer better chances of pain relief than corticosteroids. However, patients with an insertional tendinopathy fared less well than those with tendinopathy of the main body of the tendon. As aprotinin is an antiinflammatory agent, its administration is probably only warranted in athletes with relatively short duration of symptoms. 111 These include drilling of the inferior pole of the patella, resection of the tibial attachment of the patellar tendon with realignment, 112 excision of macroscopic necrotic areas, 25 108 repair of macroscopic defects, 31 scarification-that is, longitudinal tenotomy/tenoplasty of the tendon, 53 percutaneous needling, 113 percutaneous longitudinal tenotomy 114 and arthroscopic assisted decompression of the tendon, possibly with excision of the inferior pole of the patella. 115 Surgical technique is based on the surgeon's opinion/ experience, as the pathophysiology of patellar tendinopathy is not known (table 5) .
Several factors confound analysis of outcome of surgery. Surgeons diVer in their diagnostic criteria, selection of cases for surgery, the actual operation performed, as well as in their postoperative protocols. DiVerent types of surgery result in diVerences in the amount of bone either excised or drilled, the margin of normal tissue excised around the macroscopically degenerative tissue, the use or avoidance of longitudinal tenotomies, and the type of closure of the tendon after surgery. Intersurgeon technical ability is another major factor, the influence of which has never been studied. Furthermore, the results of surgery should not be evaluated in isolation as a prolonged period of rehabilitation usually ensues. 35 93 Good results may be attributable in part to the relative rest, and therefore randomised studies are needed.
Conclusion
When treating patients with patellar tendinopathy, clinicians must emphasise to these patients that they have a degenerative, not an inflammatory, condition of their patellar tendon, which is most likely due to excessive load bearing. Clinical assessment is the key to diagnosis although the presence of abnormalities on ultrasonography or MR increases the likelihood that the patient's symptoms arise from the patellar tendon. Imaging appearances should not determine treatment. For the time being, treatment is based on clinical experience rather than on scientific rationale.
A variety of management modalities exist, including correction of the perceived underlying biomechanical problems, local physical modalities such as ice, and, when the patient is pain-free, a graduated strengthening programme emphasising functional exercises including eccentric training. Of the conservative measures available, eccentric training appears to be the most promising, but well designed controlled studies are urgently needed. Clinical experience suggests that in some patients peritendinous corticosteroid or aprotinin infiltration may be warranted as an adjunct to other appropriate treatments.
Surgery is indicated after a six to nine month trial of appropriate conservative management. Although we were not able to find a scientific report on it, percutaneous needling appears to be the least invasive procedure, followed by percutaneous longitudinal tenotomy. This latter procedure is advocated for tendinopathy in the mid-tendon, not at the patellar insertion. Open patellar tenotomy is the conventionally accepted surgical treatment of insertional patellar tendinopathy, but often requires six to nine months of rehabilitation. Arthroscopic 
